Various domestic and international studies have shown that the aminotransferase levels or AST/ALT ratio could be potential biomarkers for liver functional impairment, including the incidence of liver cancer and abnormalities in metabolic functions, such as hyperlipidemia and hyperglycemia [21]. Here, GPT is linked to hyperlipidemia.